Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

National Research stock

NRC
US6373722023
A1WYXP

Price

18.32
Today +/-
-0.73
Today %
-4.25 %
P

National Research stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the National Research stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the National Research stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the National Research stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze National Research's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

National Research Stock Price History

DateNational Research Price
11/5/202418.32 undefined
11/5/202419.12 undefined
11/4/202418.50 undefined
11/1/202418.16 undefined
10/31/202418.13 undefined
10/30/202417.91 undefined
10/29/202417.77 undefined
10/28/202418.77 undefined
10/25/202417.96 undefined
10/24/202418.30 undefined
10/23/202418.43 undefined
10/22/202418.69 undefined
10/21/202418.83 undefined
10/18/202419.95 undefined
10/17/202419.75 undefined
10/16/202419.45 undefined
10/15/202419.44 undefined
10/14/202419.04 undefined
10/11/202418.86 undefined
10/10/202418.71 undefined
10/9/202419.19 undefined
10/8/202419.49 undefined

National Research Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into National Research, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by National Research from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects National Research’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of National Research. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into National Research’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing National Research’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on National Research’s growth potential.

National Research Revenue, EBIT and net profit per share

DateNational Research RevenueNational Research EBITNational Research Net Income
2023148.58 M undefined40.09 M undefined30.96 M undefined
2022151.6 M undefined60.5 M undefined31.8 M undefined
2021148 M undefined50.5 M undefined37.4 M undefined
2020133.3 M undefined42.2 M undefined37.2 M undefined
2019128 M undefined43 M undefined32.3 M undefined
2018119.7 M undefined35.3 M undefined29.9 M undefined
2017117.6 M undefined34.2 M undefined22.8 M undefined
2016109.4 M undefined31.2 M undefined20.3 M undefined
2015102.3 M undefined26.4 M undefined17.5 M undefined
201498.8 M undefined28.3 M undefined18.2 M undefined
201392.6 M undefined24.8 M undefined15.5 M undefined
201286.4 M undefined22.7 M undefined15.1 M undefined
201175.8 M undefined18.7 M undefined11.6 M undefined
201063.4 M undefined14.6 M undefined8.5 M undefined
200957.7 M undefined13.7 M undefined8.5 M undefined
200851 M undefined12 M undefined7.4 M undefined
200748.9 M undefined11.4 M undefined6.8 M undefined
200643.8 M undefined9.9 M undefined5.9 M undefined
200532.4 M undefined8.4 M undefined5.2 M undefined
200429.7 M undefined7.4 M undefined4.6 M undefined

National Research Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
19921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
226812161718181722262932434851576375869298102109117119128133148151148
--200.0033.3350.0033.336.255.88--5.5629.4118.1811.5410.3434.3811.636.2511.7610.5319.0514.676.986.524.086.867.341.717.563.9111.282.03-1.99
50.0050.0050.0062.5050.0056.2547.0638.8950.0052.9454.5553.8555.1756.2555.8156.2552.9457.8960.3262.6759.3057.6158.1655.8857.8058.1260.5063.2863.1664.1962.2562.16
113569879912141618242727333847515357576368728184959492
0012342232677891112131418222428263134354342506040
--16.6725.0025.0025.0011.7611.1116.6711.7627.2726.9224.1425.0020.9322.9223.5322.8122.2224.0025.5826.0928.5725.4928.4429.0629.4133.5931.5833.7839.7427.03
001333012134455678811151518172022293237373130
---200.00----100.00-50.00200.0033.33-25.00-20.0016.6714.29-37.5036.36-20.00-5.5617.6510.0031.8210.3415.63--16.22-3.23
--------------------------------
--------------------------------
3.13.13.13.13.13.23.73.53.53.53.63.73.63.63.53.53.43.43.423.924.324.624.624.524.625.228.125.725.725.625.124.67
--------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The National Research Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the National Research is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                         
1.54.317.912.9129.87.71116.21910.323.51.12.53.58.18.322.14042.13334.71313.534.754.4256.65
31.53.743.533.86.56.54.66.797.87.36.410.312.113.112.39.311.212.414.811.911.714.213.814.612.46
0000000.3000.60.20.90.20.60.81.300.10.41.10.200.40.40.11.30.80.70.16
00000000000000000000000000000
000.30.40.30.40.50.50.81.211.11.11.422.222.41.82.71.51.62.33.13.83.94.83.45.08
4.55.821.917.315.813.212.31823.525.418.21312.610.411.717.322.223.936.653.1554752.228.429.154.173.843.724.36
0.30.30.52.37.513.212.912.312.212.411.911.71213.71414.513.612.511.912.111.111.812.414.215.21313.417.830.27
00000000000000000000000000000
00000000000000000000000000000
0000.60.40.40.40.80.91.836.55.68.16.98.67.15.84.85.53.83.12.82.11.71.41.81.61.47
0005.55.14.78.27.798.311.53031.139.339.955.157.757.857.658.557.857.95857.857.957.361.661.661.61
0.200.20.60.50.1000000.30.60.60.10.20.10.10.20.20.30.81.95.56.77.67.15.74.73
0.50.30.7913.518.421.520.822.122.526.448.549.361.760.978.478.576.274.576.37373.675.179.681.579.383.986.798.08
56.122.626.329.331.633.838.845.647.944.661.561.972.172.695.7100.7100.1111.1129.4128120.6127.3108110.6133.4157.7130.4122.44
                                                         
000000000000000000000000000031
0016.816.816.81717.318.118.919.32021.823.527.227.92931.139.542.244.944.146.751157.3162.2171.8173.9175.5178.21
1.82.11.31.73.25.97.611.415.820.423.426.53033.737.941.34744.75873.765.371.577.6-106.3-93.4-61.4-36.1-25.2-30.53
00000000-0.40-0.10.40.900.81.10.91.10.3-0.8-3-2.6-1.6-2.9-2.2-2.4-2.400
00000000000000000000000000000
1.82.118.118.52022.924.929.534.339.743.348.754.460.966.671.47985.3100.5117.8106.4115.612748.166.6108135.4150.3147.71
0.40.50.30.71.71.81.40.60.50.41.11.21.10.90.610.80.30.70.80.60.80.60.61.31.11.91.21.3
0.50.81.41.71.81.20.911.41.42.222.92.72.85.756.76.89.47.17.69.58.61010.113.19.19.43
2.22.52.45.93.51.82.63.34.745.48.39.912.911.917.716.615.81415.23420.421.13422.315.920.618.418.24
00003.5000000000000000000000000
00000.10.10.10.10.10.21.53.11.14.60.81.8212.52.42.52.52.81.13.94.64.64.74.87.24
3.13.84.18.310.64.9556.7610.214.61521.116.126.224.435.323.927.944.231.632.347.138.231.740.333.536.2
0000.105.35.254.94.7081.98.46.914.3130.28.15.73.30.9034.230.427.322.617.729.49
0000000.20.71.21.81.92.32.74.15.16.27.67.56.97.45.74.946.37.47.375.34.14
0.10.30.20.50.10.1000.50.300.1000.20.50.20.30.50.70.60.60.91.41.92.82.223.65
0.10.30.20.60.15.45.45.76.66.81.910.44.612.512.22120.8815.513.89.66.44.941.939.737.431.82537.28
3.24.14.38.910.710.310.410.713.312.812.12519.633.628.347.245.243.339.441.753.83837.28977.969.172.158.573.48
56.222.427.430.733.235.340.247.652.555.473.77494.594.9118.6124.2128.6139.9159.5160.2153.6164.2137.1144.5177.1207.5208.8221.2
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of National Research provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand National Research's financial health and stability.

Assets

National Research's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that National Research must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of National Research after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into National Research's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (k)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
1333012134455678811151518172022303237373130
000000111121222345433444557655
0000000000000001,00001,000000-1,000001,0001,00000-1,000-1,000
0-12-100-20-1100-233-100-10300010-41-31
000020000000112111121233221152
000000000000000000000000121110
000000101122333343589991226510128
21613323487861415131418191926212628394040463638
0000-1-4-6-1-1-1-2-1-1-1-2-2-1-2-2-2-2-2-3-4-5-4-3-5-9-15
00-1-12-2-7-1-5-4-5-40-130-15-3-16-6-2-2-5-1-3-6-5-4-3-8-9-15
000-110-24-3-3-3-21-121-120-15-400-310-1000-300
000000000000000000000000000000
00000010000-39-89-58-1-2-2-2-2-2-2-35-3-3-4-414
00016-100000-2-500-8000100-100001-3-27-18
0-2-312-101000-2-116-11-1-93-6-16-2-1-16-32-21-54-36-15-18-55-40
0-2,000-3,000-4,000000000000000001,00000-2,000-2,000-1,000-2,000-1,000-2,0000-2,0000
00000000000-2-2-3-3-4-5-5-17-20-10-28-16-16-31-10-9-20-36
1-1110-32-2020-202-2114013172-91-2102119-29-18
2.41.596.081.192.04-1.4-4.151.542.766.585.757.15.3612.6112.3710.7613.0615.6716.7817.1323.7118.9522.8723.2733.8836.2636.6640.8326.4322.33
000000000000000000000000000000

National Research stock margins

The National Research margin analysis displays the gross margin, EBIT margin, as well as the profit margin of National Research. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for National Research.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the National Research's sales revenue. A higher gross margin percentage indicates that the National Research retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the National Research's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the National Research's total revenue generated. When comparing the revenue margin year over year, investors can gauge the National Research's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the National Research. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the National Research's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

National Research Margin History

National Research Gross marginNational Research Profit marginNational Research EBIT marginNational Research Profit margin
202362.3 %26.98 %20.84 %
202262.34 %39.91 %20.98 %
202164.59 %34.12 %25.27 %
202063.09 %31.66 %27.91 %
201963.67 %33.59 %25.23 %
201860.23 %29.49 %24.98 %
201758.25 %29.08 %19.39 %
201658.32 %28.52 %18.56 %
201556.4 %25.81 %17.11 %
201457.79 %28.64 %18.42 %
201357.99 %26.78 %16.74 %
201259.03 %26.27 %17.48 %
201162.14 %24.67 %15.3 %
201061.2 %23.03 %13.41 %
200958.06 %23.74 %14.73 %
200853.73 %23.53 %14.51 %
200755.42 %23.31 %13.91 %
200655.48 %22.6 %13.47 %
200558.02 %25.93 %16.05 %
200456.57 %24.92 %15.49 %

National Research Stock Sales Revenue, EBIT, Earnings per Share

The National Research earnings per share therefore indicates how much revenue National Research has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue National Research earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates National Research's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of National Research’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating National Research's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

National Research Revenue, EBIT and net profit per share

DateNational Research Sales per ShareNational Research EBIT per shareNational Research Earnings per Share
20236.02 undefined1.62 undefined1.25 undefined
20226.04 undefined2.41 undefined1.27 undefined
20215.78 undefined1.97 undefined1.46 undefined
20205.19 undefined1.64 undefined1.45 undefined
20194.98 undefined1.67 undefined1.26 undefined
20184.26 undefined1.26 undefined1.06 undefined
20174.67 undefined1.36 undefined0.9 undefined
20164.45 undefined1.27 undefined0.83 undefined
20154.18 undefined1.08 undefined0.71 undefined
20144.02 undefined1.15 undefined0.74 undefined
20133.76 undefined1.01 undefined0.63 undefined
20123.56 undefined0.93 undefined0.62 undefined
20113.17 undefined0.78 undefined0.49 undefined
201018.65 undefined4.29 undefined2.5 undefined
200916.97 undefined4.03 undefined2.5 undefined
200815 undefined3.53 undefined2.18 undefined
200713.97 undefined3.26 undefined1.94 undefined
200612.51 undefined2.83 undefined1.69 undefined
20059 undefined2.33 undefined1.44 undefined
20048.25 undefined2.06 undefined1.28 undefined

National Research business model

The National Research Corporation (NRC) was founded in 1981 and is headquartered in Lincoln, Nebraska, USA. Since its inception, the company has specialized in researching customer opinions and experiences in the healthcare industry and is therefore one of the leading providers in this market. The NRC's business model consists of helping hospitals, nursing homes, and other healthcare facilities better understand and respond to the needs of their patients and employees. Over the years, the National Research Corporation has continuously expanded its range of services. The company now has several divisions, including: - NRC Health: This is NRC's main business area, which focuses on collecting, analyzing, and reporting customer opinions and experiences in the healthcare industry. NRC Health offers various survey and analysis methods to improve the quality of healthcare and increase customer satisfaction. - Transparency Solutions: This division of NRC Health focuses on creating transparency reports and performance comparisons of medical facilities. These reports are helpful for potential patients and their families to make informed decisions about which medical facilities offer the best treatment. - My InnerView: This is an NRC Health platform specifically designed for long-term care facilities. My InnerView offers survey and analysis methods to improve the quality of care and support for residents in nursing homes. - Market Insights: This division of NRC provides healthcare facilities with access to key information about employee hiring and retention, as well as market trends and competitive analysis. - Resident & Family Experience: This division of NRC focuses on capturing customer feedback and experiences in independent and assisted living facilities. By using surveys and feedback analysis, the company can improve resident and family satisfaction and optimize the customer experience in these facilities. In addition to these various divisions, NRC also offers a variety of products to help healthcare facilities improve their customer and employee experiences. These include survey tools, data analysis software, dashboards, and reporting tools. Overall, over the years, the National Research Corporation has built a strong reputation by helping customers in the healthcare industry better understand and respond to the needs of their patients and employees. The company has established itself as a trusted partner that provides valuable insights into healthcare and supports healthcare facilities in improving customer and employee satisfaction. National Research is one of the most popular companies on Eulerpool.com.

National Research SWOT Analysis

Strengths

National Research Corp (NRC) holds a strong market position in the research and insights industry, offering a range of comprehensive services to clients. With their vast experience and expertise, NRC has established a solid reputation for delivering high-quality market research and analysis.

The company has a diverse portfolio of clients across various sectors, which helps in mitigating risks and ensuring a stable revenue stream. NRC's strong client relationships and their ability to understand and address client needs have been key factors contributing to their success.

NRC's advanced technological infrastructure enables them to capture and analyze large volumes of data efficiently. By leveraging cutting-edge analytics tools, NRC can provide valuable insights and actionable recommendations to clients, enhancing their decision-making processes.

Weaknesses

Despite its strengths, NRC faces certain weaknesses that could have an impact on its performance. One such weakness is the potential overreliance on a few major clients for a significant portion of their revenue. This could pose a risk if any of these clients were to reduce their engagement or terminate contracts.

Additionally, NRC may face challenges in keeping up with rapidly evolving technology and market trends. A failure to adequately invest in research and development could result in a loss of competitive advantage and hinder the company's growth.

Opportunities

There are several opportunities that NRC can capitalize on. The increasing demand for data-driven insights in industries like healthcare, retail, and technology presents a significant growth opportunity for NRC. By expanding their service offerings and targeting new market segments, NRC can tap into these growing markets.

Furthermore, strategic partnerships and collaborations with other leading organizations can help NRC expand its market reach and gain access to new resources and expertise. Joint ventures or mergers and acquisitions could also be viable options for NRC to accelerate their growth and expand their client base.

Threats

NRC faces various threats that could potentially impact its business operations. Intense competition within the market research industry poses a significant threat, as other companies may offer similar services at competitive prices. NRC needs to continuously differentiate itself and innovate to maintain a competitive edge.

Economic downturns or fluctuations in the business environment can also pose risks to NRC's revenue and profitability. Reduced client spending or budget cuts in market research could directly affect the demand for NRC's services.

Moreover, data security and privacy concerns are growing threats in today's digital landscape. NRC needs to prioritize implementing robust data protection measures and ensure compliance with privacy regulations to maintain client trust and mitigate potential breaches.

National Research Revenue by Segment

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

National Research Revenue by Segment

Segmente20232022202120202019
Subscription Services140.17 M USD141.98 M USD137.01 M USD--
Service4.07 M USD4.23 M USD3.22 M USD--
Fixed, Non-subscription Services3.5 M USD3.13 M USD3.07 M USD--
Unit Price Services834,000 USD2.22 M USD4.67 M USD--

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

National Research Revenue by Segment

Segmente20232022202120202019
Subscription Services---122.5 M USD114.33 M USD
Unit Price Services---4.94 M USD5.9 M USD
Service---2.93 M USD4.99 M USD
Fixed, Non-subscription Services---2.91 M USD2.77 M USD

National Research Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

National Research Revenue by Segment

DateCANADAUnited States
2023--148.58 M USD
2022-793,000 USD150.78 M USD
2021-2.97 M USD144.99 M USD
2020-2.97 M USD130.31 M USD
2019-3.61 M USD124.37 M USD
2018-4.24 M USD115.45 M USD
2017-4.67 M USD112.89 M USD
2016-4.94 M USD104.45 M USD
2015-5.25 M USD97.1 M USD
20146.57 M USD--

National Research Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

National Research historical P/E ratio, EBIT multiple, and P/S ratio

National Research shares outstanding

The number of shares was National Research in 2023 — This indicates how many shares 24.673 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue National Research earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates National Research's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of National Research’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating National Research's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

National Research dividend history and estimates

In 2023, National Research paid a dividend amounting to 1.48 USD. Dividend means that National Research distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for National Research provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify National Research’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating National Research's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

National Research Dividend History

DateNational Research Dividend
20231.48 undefined
20220.84 undefined
20210.48 undefined
20200.21 undefined
20190.78 undefined
20180.63 undefined
20170.4 undefined
20160.34 undefined
20150.26 undefined
20140.06 undefined
20130.76 undefined
20121.53 undefined
20111.53 undefined
20101.53 undefined
20091.53 undefined
20081.53 undefined
20071.53 undefined
20061.53 undefined
20050.38 undefined

National Research dividend payout ratio

In 2023, National Research had a payout ratio of 37.83%. The payout ratio indicates the percentage of the company's profits that National Research distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for National Research represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for National Research could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate National Research's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

National Research Payout Ratio History

DateNational Research Payout ratio
202337.83 %
202266.14 %
202132.88 %
202014.48 %
201961.9 %
201858.88 %
201744.44 %
201640.96 %
201536.62 %
20148.11 %
2013121.05 %
2012246 %
2011317.75 %
201061.01 %
200961.01 %
200869.96 %
200778.22 %
200690.25 %
200526.48 %
200437.83 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for National Research.

National Research latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240 0.26  (0 %)2024 Q2
3/31/20240 0.27  (0 %)2024 Q1
12/31/20230 0.36  (0 %)2023 Q4
9/30/20230 0.32  (0 %)2023 Q3
6/30/20230 0.29  (0 %)2023 Q2
3/31/20230 0.28  (0 %)2023 Q1
12/31/20220 0.27  (0 %)2022 Q4
6/30/20190.26 0.29  (10.43 %)2019 Q2
3/31/20190.31 0.32  (2.2 %)2019 Q1
6/30/20180.26 0.28  (6.63 %)2018 Q2
1
2

Eulerpool ESG Scorecard© for the National Research stock

Eulerpool World ESG Rating (EESG©)

32/ 100

🌱 Environment

4

👫 Social

38

🏛️ Governance

56

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees60.7
Percentage of women in management
Percentage of Asian employees5.3
Share of Asian management
Percentage of Hispanic/Latino employees6.4
Hispano/Latino Management share
Percentage of Black employees3.5
Black Management Share
Percentage of white employees83
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

National Research shareholders

%
Name
Stocks
Change
Date
20.25263 % Amandla MK Trust4,755,317-7,2143/20/2024
16.41518 % Common Property Trust LLC3,854,284-918,2383/20/2024
12.96979 % Kayne Anderson Rudnick Investment Management, LLC3,045,30618,8916/30/2024
4.09504 % The Vanguard Group, Inc.961,51620,1036/30/2024
4.06498 % BlackRock Institutional Trust Company, N.A.954,45824,5506/30/2024
3.44573 % Atlanta Capital Management Company, L.L.C.809,057-76,4716/30/2024
2.61710 % Dimensional Fund Advisors, L.P.614,495-23,8946/30/2024
1.84363 % Renaissance Technologies LLC432,88454,6006/30/2024
1.73635 % Geode Capital Management, L.L.C.407,69438,0796/30/2024
1.48762 % State Street Global Advisors (US)349,294-5,0516/30/2024
1
2
3
4
5
...
10

National Research Executives and Management Board

Mr. Kevin Karas(65)
National Research Chief Financial Officer, Senior Vice President - Finance, Treasurer, Secretary
Compensation 403,606
Ms. Helen Hrdy(58)
National Research Chief Customer Officer
Compensation 402,097
Ms. Parul Bhandari(48)
National Research Independent Director
Compensation 218,745
Mr. Michael Hays(68)
National Research President, Chief Executive Officer, Director (since 1981)
Compensation 181,173
Mr. John Nunnelly(70)
National Research Lead Independent Director
Compensation 175,006
1
2
3

Most common questions regarding National Research

What values and corporate philosophy does National Research represent?

National Research Corp (NRC) represents a strong set of values and corporate philosophy. With a commitment to excellence, NRC upholds integrity, transparency, and accountability in all its operations. The company places great emphasis on client satisfaction and strives to provide exceptional healthcare performance measurement solutions. NRC values innovation and continuously seeks new ways to improve patient care outcomes. By leveraging advanced data analytics, NRC assists healthcare organizations in delivering high-quality services, promoting positive patient experiences, and achieving operational efficiency. NRC's corporate philosophy revolves around fostering trust and collaboration with clients, driving meaningful advancements in the healthcare industry.

In which countries and regions is National Research primarily present?

National Research Corp primarily operates in the United States. With its headquarters in Lincoln, Nebraska, the company provides performance measurement and improvement services to healthcare organizations across all 50 states. National Research Corp's dedication to serving the US healthcare industry has positioned it as a leading provider of patient satisfaction surveys, market insights, and quality improvement solutions.

What significant milestones has the company National Research achieved?

National Research Corp (NRC) has achieved significant milestones throughout its history. These include becoming a leading provider of patient satisfaction surveys and market research to healthcare organizations. NRC has built a reputation for delivering actionable insights and innovative solutions. The company has expanded its services globally and established strategic partnerships with major healthcare organizations. NRC's commitment to excellence has earned it numerous industry accolades, such as being named one of the "Best Places to Work in Healthcare" multiple times. With its strong track record and industry recognition, National Research Corp continues to be a trusted partner for healthcare organizations worldwide.

What is the history and background of the company National Research?

National Research Corp is a leading provider of analytics and insights to healthcare organizations. With a rich history spanning over three decades, the company has established itself as a trusted partner in delivering transformative solutions. National Research Corp's journey began in 1981, when it was founded by Samuel K. Hazen and Michael D. Hays to address the emerging need for healthcare quality measurement and improvement. Since then, National Research Corp has consistently pioneered innovative technologies and data-driven approaches to help healthcare providers enhance patient experiences, achieve operational excellence, and drive positive outcomes. Today, their comprehensive suite of services continues to empower healthcare institutions worldwide, making National Research Corp a respected global leader in the industry.

Who are the main competitors of National Research in the market?

The main competitors of National Research Corp in the market include Press Ganey Holdings Inc., NRC Health Inc., and Advisory Board Company.

In which industries is National Research primarily active?

National Research Corp is primarily active in the healthcare industry. With years of expertise and a comprehensive suite of research solutions, National Research Corp provides valuable insights and improvement strategies to healthcare organizations. Their services aim to enhance patient satisfaction, manage reputation, and drive overall healthcare excellence. With a strong focus on the healthcare sector, National Research Corp has established itself as a trusted partner for healthcare providers, delivering data-driven solutions to improve quality, safety, and patient experience.

What is the business model of National Research?

National Research Corp is a leading provider of analytics and insights for the healthcare industry. The company offers a comprehensive suite of performance measurement solutions to help healthcare organizations enhance patient experiences, improve outcomes, and optimize operational efficiency. By collecting and analyzing data from various sources, National Research Corp enables its clients to make informed decisions and drive positive change in the industry. Through its innovative business model, the company empowers healthcare providers to measure and improve their performance, ultimately leading to better patient care and satisfaction.

What is the P/E ratio of National Research 2024?

The P/E ratio cannot be calculated for National Research at the moment.

What is the P/S ratio of National Research 2024?

The P/S cannot be calculated for National Research currently.

What is the Quality Investing of National Research?

The Quality Investing for National Research is 6/10.

What is the revenue of National Research 2024?

The revenue cannot currently be calculated for National Research.

How high is the profit of National Research 2024?

The profit cannot currently be calculated for National Research.

What is the business model of National Research

National Research Corp (NRC) is a leading company in the field of health care performance tools. Their business model is to provide their customers, mainly in the healthcare industry, with tools and data to improve patient experience, increase compliance with regulations, and enhance profitability. NRC works with various sectors, including hospitals, nursing homes, medical groups, rehabilitation centers, hospices, pharmacies, and health insurers. NRC offers a wide range of products and services to meet their customers' needs. The key products include: - MIND: A digital platform that provides healthcare executives with a 360-degree view of their organization. With MIND, users can access data to make informed decisions, respond to changes, and optimize their business. - Market Insights: A tool that allows customers to gather, analyze, and make informed decisions from data on their patients and competitors. Market Insights helps customers maximize their growth potential and better understand their competitive environment. - Transparency: An online rating system based on patient feedback. Transparency allows customers to collect, measure, and analyze feedback from their patients to improve their patient experience and remain competitive. - Family Experience: A module that enables nursing homes to enhance the experience of patients and family members. Family Experience helps customers increase their home stay rate and improve financial performance. In addition to providing products and services, NRC offers a variety of services to help their customers increase efficiency and profitability. This includes training healthcare staff to optimize the use of NRC's tools. NRC also offers professional services to optimize their customers' business operations, such as consulting services or data analysis. NRC's business model is focused on helping their customers achieve their goals and optimize their business operations. The company earns revenue through the sale of products, services, and additional features. Most of NRC's products are subscription-based and typically billed annually to customers. Overall, NRC's business model is centered around offering data-driven tools and services to their healthcare customers to increase profitability and improve their success in patient experience and their environment. NRC is an established company that has been operating for over 30 years and serves customers in the USA, Canada, and the Middle East.

What is the National Research dividend?

National Research pays a dividend of 0.84 USD distributed over payouts per year.

How often does National Research pay dividends?

The dividend cannot currently be calculated for National Research or the company does not pay out a dividend.

What is the National Research ISIN?

The ISIN of National Research is US6373722023.

What is the National Research WKN?

The WKN of National Research is A1WYXP.

What is the National Research ticker?

The ticker of National Research is NRC.

How much dividend does National Research pay?

Over the past 12 months, National Research paid a dividend of 1.48 USD . This corresponds to a dividend yield of about 8.08 %. For the coming 12 months, National Research is expected to pay a dividend of 1.48 USD.

What is the dividend yield of National Research?

The current dividend yield of National Research is 8.08 %.

When does National Research pay dividends?

National Research pays a quarterly dividend. This is distributed in the months of April, July, October, January.

How secure is the dividend of National Research?

National Research paid dividends every year for the past 19 years.

What is the dividend of National Research?

For the upcoming 12 months, dividends amounting to 1.48 USD are expected. This corresponds to a dividend yield of 7.74 %.

In which sector is National Research located?

National Research is assigned to the 'Health' sector.

Wann musste ich die Aktien von National Research kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of National Research from 1/10/2025 amounting to 0.12 USD, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

When did National Research pay the last dividend?

The last dividend was paid out on 1/10/2025.

What was the dividend of National Research in the year 2023?

In the year 2023, National Research distributed 0.84 USD as dividends.

In which currency does National Research pay out the dividend?

The dividends of National Research are distributed in USD.

All fundamentals about National Research

Our stock analysis for National Research Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of National Research Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.